CorMedix Inc.

CRMDNASDAQUSD
7.64 USD
0.22 (3.02%)🟢LIVE (AS OF 10:42 AM EDT)
🟢Market: OPEN
Open?$7.53
High?$7.74
Low?$7.38
Prev. Close?$7.42
Volume?532.8K
Avg. Volume?1.1M
VWAP?$7.61
Rel. Volume?0.47x
Bid / Ask
Bid?$7.62 × 200
Ask?$7.63 × 400
Spread?$0.01
Midpoint?$7.63
Valuation & Ratios
Market Cap?586.6M
Shares Out?79.1M
Float?70.9M
Float %?90.5%
P/E Ratio?3.60
P/B Ratio?1.45
EPS?$2.06
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.11Strong
Quick Ratio?1.94Adequate
Cash Ratio?0.83Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
3.6CHEAP
P/B?
1.45CHEAP
P/S?
1.88CHEAP
P/FCF?
3.4CHEAP
EV/EBITDA?
2.7CHEAP
EV/Sales?
1.42CHEAP
Returns & Efficiency
ROE?
40.2%STRONG
ROA?
19.7%STRONG
Cash Flow & Enterprise
FCF?$172.8M
Enterprise Value?$442.9M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Employees
191
Market Cap
586.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2010-05-13
Address
389 INTERPACE PKWY, SUITE 450
PARSIPPANY, NJ 07054
Phone: 908-517-9500